StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Teva Pharma (TEVA) PT Lowered to $16.50 at Wells Fargo
February 9, 2018 8:05 AM
Wells Fargo lowered its price target on Teva Pharma (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Teva Pharma (TEVA) PT Lowered to $23 at Goldman Sachs; Remains Bullish as Expectations Reset
February 9, 2018 8:52 AM
Teva Pharma (TEVA): OK Quarter But Headwinds Reduce PT - Deutsche Bank
February 9, 2018 7:14 AM
RBC Capital Upgrades Teva Pharma (TEVA) to Sector Perform
February 9, 2018 6:09 AM
Gabelli Downgrades Teva Pharma (TEVA) to Hold Citing FY 2018 Outlook
February 9, 2018 5:32 AM
Piper Jaffray Downgrades Teva Pharma (TEVA) to Underweight
February 9, 2018 5:04 AM
Teva Pharma (TEVA) Cut to Junk by S&P; to BB/Stable from BBB-/Watch
February 8, 2018 5:28 PM
Teva Pharma (TEVA) PT Lowered to $16 at Cowen
February 8, 2018 12:37 PM
Teva Pharma (TEVA) Leaving Room for Upside Surprise in EBITDA Guidance - Evercore ISI
February 8, 2018 8:32 AM
Teva Pharma (TEVA) Tops Q4 EPS by 17c, FY18 Guidance Falls Short of Views
February 8, 2018 7:05 AM
Teva Reports 2017 Full Year and Fourth Quarter Financial Results
February 8, 2018 7:01 AM
